Cart
sales@molnova.com
Temozolomide Acid
CAS No. 113942-30-6
Temozolomide Acid( TMZA )
Catalog No. M22721 CAS No. 113942-30-6
Temozolomide Acid is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 31 | In Stock |
|
| 200MG | 45 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTemozolomide Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionTemozolomide Acid is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.
-
DescriptionTemozolomide Acid is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.
-
In Vitro——
-
In Vivo——
-
SynonymsTMZA
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number113942-30-6
-
Formula Weight195.14
-
Molecular FormulaC6H5N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble; Water:Insoluble
-
SMILESCn1nnc2c(ncn2c1=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee S Y . Temozolomide resistance in glioblastoma multiforme[J]. Genes & Diseases, 2016, 3( 3):198-210.
molnova catalog
related products
-
Ganoderic acid M
Ganoderic acid Me and/or ganoderic acid T have obvious action for inhibiting human tumor cell growth or proliferation, at the same time its toxicity for normal cells is low.
-
KEEAE
KEEAE
-
Erbulozole
Erbulozole (R 55104) is a potent synthetic microtubule inhibitor with anti-invasive, anti-tumor, and radiosensitizing activities that induces Wernicke's encephalopathy-like neurotoxicity.
